Type L1 steroid-induced osteonecrosis of the femoral head through femoral head and neck junction decompression by fenestration: a single-center prospective clinical study

doi:10.3969/j.issn.2095-4344.2396

Abstract

Abstract: BACKGROUND: Osteonecrosis of the femoral head is a refractory disease in department of orthopedics. Especially with steroid-induced osteonecrosis, incidence rate is high, and it is easy to collapse. Increasing knowledge of hormone necrosis will help early identification and intervention, and choose reasonable treatment measures to improve prognosis.
OBJECTIVE: To investigate the clinical effects and influencing factors in the treatment of different kinds of steroid-induced osteonecrosis of the femoral head of CJFH type L1 patients through femoral head and neck junction decompression by fenestration and bone grafting.
METHODS: Clinical data of 82 patients (106 hips) with CJFH type L1 steroid-induced osteonecrosis of the femoral head, who underwent femoral head and neck junction decompression by fenestration in China-Japan Friendship Hospital, were analyzed. The clinical effect evaluation consisted of two parts: Harris hip score system, the observation of bilateral hip joint and frog position film. Clinical endpoint events were marked by poor Harris hip score < 70, progressive collapse of the femoral head with/without obvious clinical manifestation. Univariate and multivariate analyses were used to analyze the influence of gender, age, etiology, preoperative ARCO stage, onset time and preoperative Harris score on prognosis.
RESULTS AND CONCLUSION: (1) All patients were followed up, and the mean duration was 3-51 months. (2) Based on Harris hip score of the last follow-up, the results were excellent in 4 hips, good in 33 hips, fair in 50 hips, and poor in 19 hips. The excellent and good rate was 34.9% (37/106). Harris hip score was higher in the final follow-up (83.1±14.3) than that before surgery (64.4±9.8) (P < 0.05). (3) Imaging results demonstrated that there were 15 hips with progressive collapse of the femoral head, and 6 hips without obvious clinical symptoms. (4) The 26 hips were classified as clinical failed. Univariate and multivariate analyses showed that preoperative Harris hip score < 70 was the independent risk factor for prognosis of osteonecrosis of the femoral head (P < 0.05). There was no significant difference among different types of steroid-induced osteonecrosis of the femoral head. (5) The method through femoral head and neck junction decompression by fenestration and bone grafting has a good effectiveness in patients with type L1 steroid-induced osteonecrosis of the femoral head in short and medium terms, but preoperative Harris hip score < 70 is a risk factor affecting the prognosis of hip preservation.

Key words: bone, osteonecrosis of the femoral head, corticosteroid, decompression, bone graft, hip preservation, prognosis, risk

CLC Number:

Liu Lihua, Sun Wei, Wang Yunting, Gao Fuqiang, Cheng Liming, Li Zirong, Wang Jiangning. Type L1 steroid-induced osteonecrosis of the femoral head through femoral head and neck junction decompression by fenestration: a single-center prospective clinical study[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(6): 906-911.

Figures/Tables 3

References

[1] MONT MA, PIVEC R, BANERJEE S, et al. High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplasty. 2015;30(9):1506-1512.
[2] WANG XS, ZHUANG QY, WENG XS, et al. Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients. Chin Med J (Engl). 2013;126(2):290-295.
[3] KAMEDA H, AMANO K, NAGASAWA H, et al. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. Intern Med. 2009;48(22):1931-1938.
[4] CE P, GEDIZLIOGLU M, GELAL F, et al. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur J Neurol. 2006;13(8):857-861.
[5] SAITO M, UESHIMA K, FUJIOKA M, et al. Corticosteroid administration within 2 weeks after renal transplantation affects the incidence of femoral head osteonecrosis. Acta Orthop. 2014;85(3):266-270.
[6] EKINCI R, BALCI S, CELIK G, et al. Symptomatic multifocal avascular necrosis in an adolescent with neuropsychiatric systemic lupus erythematosus. Reumatologia. 2019;57(3):182-187.
[7] HUSSEIN S, SUITNER M, BELAND-BONENFANT S, et al. Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis. J Rheumatol. 2018;45(10):1462-1476.
[8] FUKUSHIMA W, FUJIOKA M, KUBO T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468(10):2715-2724.
[9] NAKAMURA J, OHTORI S, SAKAMOTO M, et al. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence. Clin Exp Rheumatol. 2010;28(1):13-18.
[10] MATTANO LJ, DEVIDAS M, NACHMAN JB, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-915.
[11] MCAVOY S, BAKER KS, MULROONEY D, et al. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16(9):1231-1236.
[12] LIM CY, ONG KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol. 2013;68(7):e397-e411.
[13] SUN W, LI ZR, SHI ZC, et al. Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. Int Orthop. 2006; 30(3):143-146.
[14] MEIER R, KRAUS TM, SCHAEFFELER C, et al. Bone marrow oedema on MR imaging indicates ARCO stage 3 disease in patients with AVN of the femoral head. Eur Radiol. 2014;24(9):2271-2278.
[15] CARDENIERS JW. ARCO international stage of osteonecrosis. ARCO Newsletter. 1993;5:79-82.
[16] MAUS U, ROTH A, TINGART M, et al. S3 Guideline. Part 3: non-traumatic avascular necrosis in adults-surgical treatment of atraumatic avascular femoral head necrosis in adults. Z Orthop Unfall. 2015;153(5):498-507.
[17] 李子荣, 刘朝晖, 孙伟, 等. 基于三柱结构的股骨头坏死分型——中日友好医院分型[J]. 中华骨科杂志,2012,32(6):515-520.
[18] 孙伟, 李子荣, 高福强, 等. 磷酸三钙多孔生物陶瓷修复股骨头坏死[J]. 中国组织工程研究,2014,18(16):2474-2479.
[19] SUN W, LI ZR, WANG BL, et al. Relationship between preservation of the lateral pillar and collapse of the femoral head in patients with osteonecrosis. Orthopedics. 2014;37(1): e24-e28.
[20] ROSENWASSER MP, GARINO JP, KIERNAN HA, et al. Long term followup of thorough debridement and cancellous bone grafting of the femoral head for avascular necrosis. Clin Orthop Relat Res. 1994;(306):17-27.
[21] MONT MA, ETIENNE G, RAGLAND PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;(417):84-92.
[22] 李子荣. 股骨头坏死临床诊疗规范[J]. 中华骨与关节外科杂志, 2015,8(1):1-6.
[23] ERIVAN R, CAPUTO T, RIOUACH H, et al. Primary total hip replacement in Ficat-Arlet stage 3 and 4 osteonecrosis: a retrospective study at a minimum 12-year follow-up. Eur J Orthop Surg Traumatol. 2020;30(5): 845-850.
[24] PARK CW, LIM SJ, KIM JH, et al. Hip resurfacing arthroplasty for osteonecrosis of the femoral head: Implant-specific outcomes and risk factors for failure. J Orthop Translat. 2020;21:41-48.
[25] KOBAYASHI S, KUBO T, IWAMOTO Y, et al. Nationwide multicenter follow-up cohort study of hip arthroplasties performed for osteonecrosis of the femoral head. Int Orthop. 2018;42(7):1661-1668.
[26] PIERCE TP, ELMALLAH RK, JAUREGUI JJ, et al. Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review. Curr Rev Musculoskelet Med. 2015;8(3):246-251.
[27] 李子荣. 股骨头坏死:早期诊断与个体化治疗[J]. 中国矫形外科杂志, 2013,21(19):1909-1911.
[28] ANIS HK, SODHI N, EHIOROBO JO, et al. Joint preservation procedures for osteonecrosis. Instr Course Lect. 2020,69:129-138.
[29] 左伟,孙伟,高福强,等. 经头颈部开窗打压植骨治疗股骨头已部分塌陷股骨头坏死疗效分析[J]. 中国修复重建外科杂志, 2016, 30(4):397-401.
[30] SEYLER TM, MARKER DR, ULRICH SD, et al. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Clin Orthop Relat Res. 2008;466(5):1125-1132.
[31] SUN W, LI Z, GAO F, et al. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLoS One. 2014;9(6):e100424.
[32] EWARD WC, RINEER CA, URBANIAK JR, et al. The vascularized fibular graft in precollapse osteonecrosis: is long-term hip preservation possible? Clin Orthop Relat Res. 2012;470(10):2819-2826.
[33] PHEMISTER DB. Treatment of the necrotic head of the femur in adults. J Bone Joint Surg Am. 1949;31A(1):55-66.
[34] 陈雷雷, 洪志楠, 洪郭驹, 等. 打压支撑植骨术治疗股骨头坏死的中长期疗效与影响因素分析[J]. 中华骨科杂志, 2018,38(7):403-410.
[35] MEYERS MH, JONES RE, BUCHOLZ RW, et al. Fresh autogenous grafts and osteochondral allografts for the treatment of segmental collapse in osteonecrosis of the hip. Clin Orthop Relat Res. 1983;(174):107-112.
[36] SULTAN AA, KHLOPAS A, SURACE P, et al. The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: indications, techniques, and outcomes. Int Orthop. 2019;43(6):1315-1320.
[37] PIERCE TP, ELMALLAH RK, JAUREGUI JJ, et al. A current review of non-vascularized bone grafting in osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):240-245.
[38] MONT MA, ZYWIEL MG, MARKER DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92(12): 2165-2170.
[39] SHIGEMURA T, NAKAMURA J, KISHIDA S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology(Oxford). 2011;50(11):2023-2028.
[40] SEKIYA F, YAMAJI K, YANG K, et al. Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus. Rheumatol Int. 2010;30(12):1587-1593.
[41] MELONI MC, HOEDEMAEKER WR, FORNASIER V. Failed vascularized fibular graft in treatment of osteonecrosis of the femoral head. A histopathological analysis. Joints. 2016;4(1):24-30.
[42] HAUZEUR JP, MALAISE M, DE MAERTELAER V. A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. Int Orthop. 2016;40(7):1347-1351.
[43] MONT MA, CARBONE JJ, FAIRBANK AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;(324):169-178.